Meg Brady, Nupsala Account Manager, is joined by Dr Simon Constable, Advanced Practitioner in Equine Orthopaedic and Soft Tissue Surgery and owner of Simon Constable Equine Vets in the northwest of England. Simon shares his real-world experience using undifferentiated equine umbilical mesenchymal stem cells across both soft-tissue and early-onset joint cases.

He talks through how he selects cases, why timing and diagnostics matter, and how he manages owner expectations in disciplines where competition schedules and performance pressure can shape clinical decisions.

Simon also discusses client communication, insurance hurdles, alternatives to steroids in laminitis-prone ponies, and some of the more memorable cases he’s worked on, including a Horse of the Year Show winner.

Simon is not endorsed by or affiliated with Nupsala or Equicord.

Time	Chapter Title
00:37	Introductions, Simon’s background and HOYS history
01:58	About the practice: caseload, client types, showing experience
04:48	Where his stem cell journey began
07:43	Moving to undifferentiated umbilical stem cells and ease of use
10:54	Case selection: acute vs chronic, soft tissue vs joints
14:42	Diagnostics and why accuracy matters
16:06	Timing: when he scans and when he injects
22:31	Owner expectations, onset of action, rehab realities
27:02	Standout cases, including the HOYS hunter
29:17	Client attitudes, insurance issues, Cascade conversations
31:12	Steroids, laminitis concerns and where orthobiologics fit
33:29	His “three” (actually ten) key takeaways for vets